MedPath

RANDOMIZED CONTROLLED TRIAL TO EVALUATE THE EFFECT OF SAHACHARADI TAILA MATRA BASTI IN THE MANAGEMENT OF KATISHOOLA VIS-A-VIS LOW BACK PAIN.

Phase 1/2
Not yet recruiting
Conditions
Spondylosis, unspecified. Ayurveda Condition: KATISHOOLA,
Registration Number
CTRI/2022/03/041492
Lead Sponsor
SANE GURUJI AROGYA KENDRA
Brief Summary

THIS IS A COMPARATIVE CLINICAL STUDY OF MATRA BASTI OF TWO DRUGS OF SAHACHARADI TAILA  AND TILA TAILA IN KATISHOOLA . THE PRIMARY OBJECTIVE IS TO EVALUATE THE EFFECT OF SAHACHARADI TAILA MATRA BASTI  AS  MODALITIES ARE SAME FOR BOTH DRUGS. ONE GROUP OF KATISHOOLA WILL BE TREATED WITH MATRA BASTI OF SAHACHARADI TAILA FOR 8 DAYS. SECOND GROUP OF KATISHOOLA WILL BE TREATED WITH MATRA BASTI OF TILA TAILA FOR 8 DAYS. OBSERVATION WILL BE DRAWN FROM THE OUTCOME OF PATIENTS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • PATIENTS HAVING SYMPTOMS OF KATISHOOLA.
  • BASTI ARHA.
  • GENDER BOTH MALE AND FEMALE.
  • AGE 20 TO 60 YEARS.
Exclusion Criteria

PATIENTS HAVING CONGENITAL STRUCTURAL DEFORMITIES PATIENTS HAVING OTHER JOINT DEFORMITIES OR DISEASES WHICH ARE NOT RELATED TO KATISHOOLA PATIENTS WITH SYSTEMIC DISEASE WHICH MAY CAUSE INTERFERENCE IN THE TREATMENT OF STUDY WILL BE EXCLUDED.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO EVALUATE THE EFFECT OF SAHACHARADI TAILA MATRA BASTI IN THE MANAGEMENT OF KATISHOOLA.TREATMENT WILL BE GIVEN FOR 8 DAYS. PATIENTS WILL BE ASSESSED ON 0, 4, 8 AND 15TH DAY.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

SANE GURUJI AROGYA KENDRA

🇮🇳

Pune, MAHARASHTRA, India

SANE GURUJI AROGYA KENDRA
🇮🇳Pune, MAHARASHTRA, India
DR SUNEERA VED PRAKASH BANGA
Principal investigator
8570063732
drsuneerabanga@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.